
OncLive Polls Spotlight Phase 3 Breast Cancer Studies Generating Buzz Ahead of ASCO 2025
As the 2025 ASCO Annual Meeting quickly approaches, several phase 3 breast cancer studies have emerged as major points of interest among oncology professionals. To assess which datasets are generating the most anticipation, OncLive® conducted informal …